Clustered Regularly Interspaced Short Palindromic Repeats – Page 4

Revival of Gene Editing Clinical Trials in China Post CRISPR Baby Scandal

2 years ago talkbio0Tagged baby scandal, Biotechnology, China, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas9, Gene Modification, Hereditary Diseases, regulatory

CRISPR baby scandal, China, gene editing, clinical trials, restart, regulations, ethics, CRISPR-Cas9, genetic diseases, biotechnology.

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

2 years ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, development aspects, Gene Modification, Genetic Research, Health care facility, Mammoth Biosciences, Partnership, Regeneron

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.

Revolutionizing Gene Editing: Regeneron and Mammoth Biosciences’ $100M Partnership

2 years ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, Collaboration, Gene Modification, healthcare innovation, Mammoth Biosciences, Regeneron

Regeneron, Mammoth Biosciences, CRISPR, gene editing, delivery system, therapeutics, collaboration, biotechnology, healthcare innovation.

Takeda Appoints Former CRISPR CMO Phuong Khanh (PK) Morrow to Lead Oncology R&D Amidst Pipeline Pruning

2 years ago talkbio0Tagged Clustered Regularly Interspaced Short Palindromic Repeats, PK

Clustered Regularly Interspaced Short Palindromic Repeats, PK